Yoram Drucker
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Yoram Nathan Drucker was the founder of Pluri, Inc. (2001), Brainstorm Cell Therapeutics, Inc. (2004) as Chief Executive & Operating Officer, Secretary, Cell Source Ltd. (2011) as Chairman, Pluri Biotech Ltd. (2004) as Director, InnoCan Pharma Corp.
(2018) as Director & Vice President-Business Development, NurExone Biologic, Inc. (2011) as Chairman & Vice President-Strategic Development, Virucure Ltd. (2005) as Chief Executive Officer, and NurExone Biologic Ltd. (2020) as Director.
Current job includes Director at I.R-Med Ltd. Former jobs include Chief Executive Officer & Chairman at Rainbow Energy Ltd. (2009-2011), CEO, President, Secretary, Treasurer & Director at Revium Recovery, Inc., Independent Director at Cell Source, Inc. (2015-2019), Director & VP-Business Development at IR-Med, Inc. (2019-2024), and Vice President-Business Development at Millennium Electric T.O.U.
Ltd.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.11.2025 | 3’655’000 ( 3.97% ) | 2 Mio $ | 31.05.2026 | |
IR-MED INC 5.24% | 04.04.2025 | 4’050’000 ( 5.24% ) | 4 050 $ | 31.01.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Gründer | 27.06.2011 |
I.R-Med Ltd.
I.R-Med Ltd. Electronic Equipment/InstrumentsElectronic Technology Provides patented interface analysis of Infra-Red light | Direktor/Vorstandsmitglied | - |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Gründer | 01.05.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| IR-MED INC. | Direktor/Vorstandsmitglied | 27.03.2024 |
| INNOCAN PHARMA CORPORATION | Gründer | 01.06.2023 |
| CELL SOURCE, INC. | Vorsitzender | 19.08.2015 |
Cell Source Ltd.
Cell Source Ltd. BiotechnologyHealth Technology Develops cell therapy treatments | Vorstandsvorsitzender | 01.10.2013 |
Rainbow Energy Ltd. | Vorstandsvorsitzender | 01.09.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 14 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Pluri, Inc.
Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Cell Source, Inc.
Cell Source, Inc. BiotechnologyHealth Technology Develops cell therapy treatments | Health Technology |
Cell Source Ltd.
Cell Source Ltd. BiotechnologyHealth Technology Develops cell therapy treatments | Health Technology |
Revium Recovery, Inc.
Revium Recovery, Inc. Food DistributorsDistribution Services Distributes alcoholic and non-alcoholic beverages | Distribution Services |
Pluri Biotech Ltd.
Pluri Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the biotechnology field, especially in stem cell research | Commercial Services |
Millennium Electric T.O.U. Ltd.
Millennium Electric T.O.U. Ltd. Building ProductsProducer Manufacturing Provides solar solutions | Producer Manufacturing |
Rainbow Energy Ltd. | |
InnoCan Pharma Corp.
InnoCan Pharma Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
I.R-Med Ltd.
I.R-Med Ltd. Electronic Equipment/InstrumentsElectronic Technology Provides patented interface analysis of Infra-Red light | Electronic Technology |
Virucure Ltd. | Commercial Services |
IR-Med, Inc.
IR-Med, Inc. Medical SpecialtiesHealth Technology Develops non-invasive devices for detecting and measuring biomarkers and molecules in the blood and in human tissue | Health Technology |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
NurExone Biologic, Inc.
NurExone Biologic, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen